Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
The review found no eligible studies for this question.
Antibiotics showed no clear difference in adverse events ‐ diarrhoea compared with placebo overall (moderate certainty).
It is very uncertain whether carvedilol changes non‐serious adverse events compared with traditional, non‐selective beta‐blockers (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Summary of findings: intravitreal anti‐VEGF plus intravitreal steroid showed no clear difference in systemic adverse events at compared with intravitreal anti‐VEGF (low certainty).
Morning bright light showed no clear difference in adverse events (frequency) compared with afternoon bright light (low certainty).
High frequency ultrasound probably leads to higher non‐serious adverse events compared with no ultrasound (moderate certainty).
Low dose calcineurin inhibitors (CNI) showed no clear difference in adverse events: malignancy compared with to standard dose CNI (low certainty).
Calcineurin inhibitor (CNI) withdrawal + mammalian target of… showed no clear difference in adverse events: malignancy compared with standard dose CNI (low certainty).
Calcineurin inhibitor (CNI) withdrawal + mammalian target of… showed no clear difference in adverse events: lymphocele compared with standard dose CNI (low certainty).
Low dose CNI calcineurin inhibitor (CNI) + mammalian target of… showed no clear difference in adverse events: malignancy compared with standard dose CNI (low certainty).
Calcineurin inhibitor (CNI) withdrawal showed no clear difference in adverse events: malignancy compared with standard dose CNI (low certainty).
It is very uncertain whether foam dressing changes adverse events, short‐term compared with hydrogel dressing (very low certainty).
It is very uncertain whether hydropolymer foam dressing changes adverse events, short‐term compared with silicone foam dressing (very low certainty).
It is very uncertain whether foam dressings changes adverse events, short‐term compared with hydrocolloid dressings (very low certainty).
The intervention may leads to higher non‐serious adverse events (low certainty).
Interferon‐α combined with targeted therapies may leads to higher adverse events (grade ≥ 3) compared with standard targeted therapy (low certainty).